Loading institutional data...
Loading institutional data...
Institutional distribution: ownership decreased -2.39% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.5M 100.0% | $14.3M 100.0% | $12.7M 100.0% | $13.3M 100.0% | $12.6M 100.0% | $18.6M 100.0% | $17.9M 100.0% | $19.0M 100.0% | $16.7M 100.0% | $12.8M 100.0% |
| Cost of Revenue | $12.1M 62.0% | $8.8M 61.8% | $8.0M 62.7% | $8.8M 66.3% | $8.6M 68.4% | $12.1M 64.8% | $9.8M 54.7% | $10.1M 53.2% | $9.3M 56.1% | $7.2M 55.8% |
| Cost of Products | — | — | — | — | — | — | — | — | — | $6.4M 50.1% |
| Cost of Services | — | — | — | — | — | — | — | — | — | $738K 5.8% |
| Gross Profit | $7.4M 38.0% | $5.5M 38.2% | $4.7M 37.3% | $4.5M 33.7% | $4.0M 31.6% | $6.6M 35.2% | $8.1M 45.3% | $8.9M 46.8% | $7.3M 43.9% | $5.7M 44.2% |
| Research & Development | $2.3M 11.6% | $1.8M 12.7% | $1.9M 14.7% | $207K 1.6% | $125K 1.0% | $555K 3.0% | $1.3M 7.5% | $1.5M 8.0% | $1.6M 9.5% | $1.6M 12.3% |
| Selling, General & Admin | $7.6M 38.9% | $7.4M 51.5% | $7.6M 59.5% | $8.8M 66.6% | $9.8M 77.2% | $9.5M 50.7% | $14.2M 79.1% | $18.6M 98.2% | $19.9M 119.6% | $17.1M 133.1% |
| Total Operating Expenses | $9.9M 50.6% | $9.2M 64.2% | $9.4M 74.2% | $9.0M 68.2% | $9.9M 78.2% | $10.0M 53.7% | $15.5M 86.5% | $20.1M 106.2% | $21.5M 129.1% | $18.6M 145.4% |
| Operating Income | -$2.5M -12.6% | -$3.7M -26.0% | -$4.7M -36.9% | -$4.6M -34.4% | -$5.9M -46.6% | -$3.4M -18.5% | -$7.4M -41.2% | -$11.3M -59.3% | -$14.2M -85.2% | -$13.0M -101.2% |
| Interest Expense | — | — | — | — | — | $12K 0.1% | $16K 0.1% | $33K 0.2% | $40K 0.2% | $3K 0.0% |
| Interest & Investment Income | — | — | — | — | — | $16K 0.1% | $50K 0.3% | $190K 1.0% | $258K 1.5% | $22K 0.2% |
| Pretax Income | -$3.4M -17.5% | -$2.9M -20.3% | -$5.0M -39.5% | -$5.2M -39.1% | -$5.4M -42.9% | -$3.9M -20.9% | -$3.5M -19.8% | -$11.3M -59.8% | -$14.3M -85.7% | -$12.9M -100.9% |
| Income Tax Expense | -$244K -1.2% | $550K 3.8% | -$196K -1.5% | -$33K -0.2% | -$332K -2.6% | $713K 3.8% | $29K 0.2% | $458K 2.4% | $50K 0.3% | -$4.3M -33.3% |
| Net Income | -$3.2M -16.3% | -$3.5M -24.2% | -$4.8M -38.0% | -$5.2M -38.8% | -$5.1M -40.3% | -$4.0M -21.2% | -$3.3M -18.5% | -$11.8M -62.2% | -$14.3M -86.0% | $9.3M 72.3% |
| Per Share | ||||||||||
| EPS (Basic) | $-1.89 | $-2.79 | $-10.63 | $-1.52 | $-1.92 | — | — | — | — | — |
| EPS (Diluted) | $-1.89 | $-2.79 | $-10.63 | $-1.52 | $-1.92 | — | — | — | — | — |
| Weighted Avg Shares (Basic) | 1.7M | 1.2M | 455K | 3.4M | 3K | — | — | — | — | — |
| Weighted Avg Shares (Diluted) | 1.7M | 1.2M | 455K | 3.4M | 3K | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$4M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -96%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $2M covers all $172000 of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2017-03-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~0.6% on $2M of debt. Interest last disclosed in FY2021 (no longer broken out).
Cash of $2M fully covers short-term debt of $222000.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Nothing notable to watch.
Where each multiple sits in its own 15-yr range · 4th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 53.2 | 54.7 | 64.8 | 68.4 | 66.3 | 62.7 | 61.8 | 62.0 |
| Gross Profit | 46.8 | 45.3 | 35.2 | 31.6 | 33.7 | 37.3 | 38.2 | 38.0 |
| R&D | 8.0 | 7.5 | 3.0 | 1.0 | 1.6 | 14.7 | 12.7 | 11.6 |
| SG&A | 98.2 | 79.1 | 50.7 | 77.2 | 66.6 | 59.5 | 51.5 | 38.9 |
| Operating Income | -59.3 | -41.2 | -18.5 | -46.6 | -34.4 | -36.9 | -26.0 | -12.6 |
| Income Tax | 2.4 | 0.2 | 3.8 | -2.6 | -0.2 | -1.5 | 3.8 | -1.2 |
| Net Income | -62.2 | -18.5 | -21.2 | -40.3 | -38.8 | -38.0 | -24.2 | -16.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SNOA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 17 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.20T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.02T | 49.6× | — | 15.7× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $916.2B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $643.4B | 24.2× | — | 6.8× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $464.4B | 111.2× | 33.2× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $362.6B | 19.9× | — | 5.6× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $340.0B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $252.6B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $244.5B | 36.5× | 31.5× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $202.8B | 26.4× | 17.4× | 5.5× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $183.3B | 21.8× | 20.0× | 6.2× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.2B | 27.5× | 19.3× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $156.1B | 20.2× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $147.3B | 41.3× | 30.5× | 6.0× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $135.8B | 48.6× | 37.3× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $130.4B | 33.5× | 28.6× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $129.4B | 18.4× | — | 2.7× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.5B | 24.8× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| LGVN | $117.4B | — | — | 97924.4× | -49.9% | 67.0% | -1894% | -400% | -400% | — | 31 |
| CVS | $116.6B | 66.0× | 11.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $108.8B | 33.9× | 18.7× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $103.4B | 23.1× | 16.3× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.7B | 15.2× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.1B | 16.4× | 15.4× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $81.0B | 18.7× | 19.4× | 5.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| SNOA | $2M | — | — | 0.1× | 36.7% | 38.0% | -16.3% | -103% | -95.7% | -0.1× | 17 |
Peers = companies sharing SNOA's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.